"canagliflozin" meaning in English

See canagliflozin in All languages combined, or Wiktionary

Noun

IPA: /ˌkæn.əɡ.ləˈfloʊ.zɪn/ [General-American]
Etymology: From cana- (of unknown origin) + -gliflozin (“sodium–glucose cotransporter inhibitor”). Etymology templates: {{af|en|cana-|-gliflozin|nocat=1|qq1=of unknown origin|t2=sodium–glucose cotransporter inhibitor}} cana- (of unknown origin) + -gliflozin (“sodium–glucose cotransporter inhibitor”) Head templates: {{en-noun|-}} canagliflozin (uncountable)
  1. (pharmacology) A drug C₂₄H₂₅FO₅S·½H₂O that lowers blood sugar by reducing the reabsorption of glucose from the kidneys and is taken orally to treat type 2 diabetes. It is marketed under the trademark Invokana and when used in combination with metformin, under the trademark Invokamet. Wikipedia link: canagliflozin Tags: uncountable Categories (topical): Pharmaceutical drugs

Download JSON data for canagliflozin meaning in English (2.4kB)

{
  "etymology_templates": [
    {
      "args": {
        "1": "en",
        "2": "cana-",
        "3": "-gliflozin",
        "nocat": "1",
        "qq1": "of unknown origin",
        "t2": "sodium–glucose cotransporter inhibitor"
      },
      "expansion": "cana- (of unknown origin) + -gliflozin (“sodium–glucose cotransporter inhibitor”)",
      "name": "af"
    }
  ],
  "etymology_text": "From cana- (of unknown origin) + -gliflozin (“sodium–glucose cotransporter inhibitor”).",
  "head_templates": [
    {
      "args": {
        "1": "-"
      },
      "expansion": "canagliflozin (uncountable)",
      "name": "en-noun"
    }
  ],
  "lang": "English",
  "lang_code": "en",
  "pos": "noun",
  "senses": [
    {
      "categories": [
        {
          "kind": "other",
          "name": "English entries with incorrect language header",
          "parents": [
            "Entries with incorrect language header",
            "Entry maintenance"
          ],
          "source": "w"
        },
        {
          "kind": "other",
          "name": "English entries with language name categories using raw markup",
          "parents": [
            "Entries with language name categories using raw markup",
            "Entry maintenance"
          ],
          "source": "w"
        },
        {
          "kind": "other",
          "name": "English terms suffixed with -gliflozin",
          "parents": [],
          "source": "w"
        },
        {
          "kind": "topical",
          "langcode": "en",
          "name": "Pharmaceutical drugs",
          "orig": "en:Pharmaceutical drugs",
          "parents": [
            "Drugs",
            "Matter",
            "Pharmacology",
            "Chemistry",
            "Nature",
            "Biochemistry",
            "Medicine",
            "Sciences",
            "All topics",
            "Biology",
            "Fundamental"
          ],
          "source": "w"
        }
      ],
      "glosses": [
        "A drug C₂₄H₂₅FO₅S·½H₂O that lowers blood sugar by reducing the reabsorption of glucose from the kidneys and is taken orally to treat type 2 diabetes. It is marketed under the trademark Invokana and when used in combination with metformin, under the trademark Invokamet."
      ],
      "id": "en-canagliflozin-en-noun-rpZknvca",
      "links": [
        [
          "pharmacology",
          "pharmacology"
        ],
        [
          "blood sugar",
          "blood sugar"
        ],
        [
          "reabsorption",
          "reabsorption"
        ],
        [
          "glucose",
          "glucose"
        ],
        [
          "kidney",
          "kidney"
        ],
        [
          "orally",
          "orally"
        ],
        [
          "metformin",
          "metformin"
        ]
      ],
      "raw_glosses": [
        "(pharmacology) A drug C₂₄H₂₅FO₅S·½H₂O that lowers blood sugar by reducing the reabsorption of glucose from the kidneys and is taken orally to treat type 2 diabetes. It is marketed under the trademark Invokana and when used in combination with metformin, under the trademark Invokamet."
      ],
      "tags": [
        "uncountable"
      ],
      "topics": [
        "medicine",
        "pharmacology",
        "sciences"
      ],
      "wikipedia": [
        "canagliflozin"
      ]
    }
  ],
  "sounds": [
    {
      "ipa": "/ˌkæn.əɡ.ləˈfloʊ.zɪn/",
      "tags": [
        "General-American"
      ]
    }
  ],
  "word": "canagliflozin"
}
{
  "etymology_templates": [
    {
      "args": {
        "1": "en",
        "2": "cana-",
        "3": "-gliflozin",
        "nocat": "1",
        "qq1": "of unknown origin",
        "t2": "sodium–glucose cotransporter inhibitor"
      },
      "expansion": "cana- (of unknown origin) + -gliflozin (“sodium–glucose cotransporter inhibitor”)",
      "name": "af"
    }
  ],
  "etymology_text": "From cana- (of unknown origin) + -gliflozin (“sodium–glucose cotransporter inhibitor”).",
  "head_templates": [
    {
      "args": {
        "1": "-"
      },
      "expansion": "canagliflozin (uncountable)",
      "name": "en-noun"
    }
  ],
  "lang": "English",
  "lang_code": "en",
  "pos": "noun",
  "senses": [
    {
      "categories": [
        "English 5-syllable words",
        "English entries with incorrect language header",
        "English entries with language name categories using raw markup",
        "English lemmas",
        "English nouns",
        "English terms suffixed with -gliflozin",
        "English terms with IPA pronunciation",
        "English uncountable nouns",
        "en:Pharmaceutical drugs"
      ],
      "glosses": [
        "A drug C₂₄H₂₅FO₅S·½H₂O that lowers blood sugar by reducing the reabsorption of glucose from the kidneys and is taken orally to treat type 2 diabetes. It is marketed under the trademark Invokana and when used in combination with metformin, under the trademark Invokamet."
      ],
      "links": [
        [
          "pharmacology",
          "pharmacology"
        ],
        [
          "blood sugar",
          "blood sugar"
        ],
        [
          "reabsorption",
          "reabsorption"
        ],
        [
          "glucose",
          "glucose"
        ],
        [
          "kidney",
          "kidney"
        ],
        [
          "orally",
          "orally"
        ],
        [
          "metformin",
          "metformin"
        ]
      ],
      "raw_glosses": [
        "(pharmacology) A drug C₂₄H₂₅FO₅S·½H₂O that lowers blood sugar by reducing the reabsorption of glucose from the kidneys and is taken orally to treat type 2 diabetes. It is marketed under the trademark Invokana and when used in combination with metformin, under the trademark Invokamet."
      ],
      "tags": [
        "uncountable"
      ],
      "topics": [
        "medicine",
        "pharmacology",
        "sciences"
      ],
      "wikipedia": [
        "canagliflozin"
      ]
    }
  ],
  "sounds": [
    {
      "ipa": "/ˌkæn.əɡ.ləˈfloʊ.zɪn/",
      "tags": [
        "General-American"
      ]
    }
  ],
  "word": "canagliflozin"
}

This page is a part of the kaikki.org machine-readable English dictionary. This dictionary is based on structured data extracted on 2024-05-18 from the enwiktionary dump dated 2024-05-02 using wiktextract (1d5a7d1 and 304864d). The data shown on this site has been post-processed and various details (e.g., extra categories) removed, some information disambiguated, and additional data merged from other sources. See the raw data download page for the unprocessed wiktextract data.

If you use this data in academic research, please cite Tatu Ylonen: Wiktextract: Wiktionary as Machine-Readable Structured Data, Proceedings of the 13th Conference on Language Resources and Evaluation (LREC), pp. 1317-1325, Marseille, 20-25 June 2022. Linking to the relevant page(s) under https://kaikki.org would also be greatly appreciated.